| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 12 Nov 2026 | 10-Q |
| 30 Oct 2026 | SCHEDULE 13G |
| 29 Sep 2026 |
Form 4: 3D Investment Partners Pte. Ltd., Formerly 10% Owner and 1 other
Sold 640,000 shares ($1.73M) |
| 29 Sep 2026 | SCHEDULE 13D/A |
| 28 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
On September 23, 2026, MediciNova, Inc. (the “Company”) amended its Lease (the “Lease”), dated July 20, 2021, between the Company and the Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026 (the ... |
| 02 Sep 2026 |
8-K: Termination of a Material Definitive Agreement
On August 31, 2026, MediciNova, Inc. (the “Company”) delivered to YA II PN, LTD. (“Yorkville”), a Notice of Termination, informing Yorkville of the Company’s election to terminate the Standby Equity Purchase Agreement, dated as of July 3... |
| 19 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 13 Aug 2026 | 10-Q |
| 25 Jun 2026 |
Form 4: Nagao Hideki, Director
Granted 44,500 Stock Option (Right to Buy) |
| 25 Jun 2026 |
Form 4: Lemerond Nicole, Director
Granted 44,500 Stock Option (Right to Buy) |
| 25 Jun 2026 |
Form 4: Beaver Carolyn, Director
Granted 44,500 Stock Option (Right to Buy) |
| 24 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
MediciNova, Inc. (the “Company”) held its 2026 annual meeting of stockholders on June 23, 2026 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securitie... |
| 14 May 2026 | 10-Q |
| 29 Apr 2026 | ARS |
| 29 Apr 2026 | DEFA14A |
| 29 Apr 2026 | DEF 14A |
| 20 Apr 2026 | PRER14A |
| 17 Apr 2026 | PRE 14A |
| 10 Mar 2026 | 10-K |
Loading...